All In Biotech

Drug Trial Radar · NCT01746485

Three Times Daily Dosing of UT-15C

A PK Evaluation of Three Times Daily Dosing of UT-15C SR Tablets in Healthy Subjects

Last checked: Nov 20, 2026Latest source record: Dec 12, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

19

Actual

Start

Jul 2012

Primary completion

Jul 2012

Study completion Jul 2012

Sponsor

Lead sponsor
United TherapeuticsIndustry
Sponsor type
Industry
First posted
Dec 11, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

To evaluate the pharmacokinetics of three-times daily dosing of UT-15C in healthy volunteers

Conditions

  • Healthy

Interventions

  • UT-15CDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Area under the curve (AUC) from 0-24hrs after 6 days of TID dosing.Time frame: 6 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • PPD Development

    Austin, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.